ArticleOphthalmology and therapy2020

A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion.

Shashikant Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.